Advertisement
News
Advertisement

Reportlinker Adds Global Diagnostic ECG Market' (2010 - 2015)

Mon, 10/18/2010 - 1:34pm
Bio-Medicine.Org

NEW YORK, Oct. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Diagnostic ECG Market' (2010 - 2015)

http://www.reportlinker.com/p0316087/Global-Diagnostic-ECG-Market'-2010---2015.html

Global diagnostic ECG Market

Electrocardiograph (ECG) is a non-invasive medical equipment that measures and monitors the heart's electrical activity, in order to diagnose cardiac problems. The DECG market offers steady growth opportunities due to the globally rising incidence of lifestyle diseases and the increasing healthcare delivery at the private physician level. While the U.S. currently forms the largest DECG market in terms of revenues, the Asian region is expected to register the highest growth rate due to its booming medical tourism industry and the immense growth opportunities and manufacturing cost advantage in countries such as India and China. The large patient base and rising income levels in these regions are also expected to boost market growth. Thus, the global DECG market is expected to register high single digit growth despite the high reimbursement costs and competitive equipment pricing in U.S. and Europe.

The global DECG market is fairly consolidated, with GE Healthcare and Philips Healthcare accounting for more than 50% of the market share. Other major players include Cardiac Science Corp., Mortara Instruments, Spacelabs Healthcare, Schiller AG, and Welch Allyn. Reverse innovations and collaborations form the major growth strategies, especially due to the growing emphasis on preventative healthcare, and the rising need for more technologically advanced products such telemetry devices. The $19 billion economic

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading